Current Prospective of NLCs in Parkinson’s Disease: An Outlook

Authors

  • Manoj Kumar Katual Rayat-Bahra Institute of Pharmacy, Education city, vpo-Bohan, Tehsil& Dist: Hoshiarpur, punjab 146001
  • Gurfateh Singh University School of Pharmaceutical Sciences, Rayat-Bahra University, Mohali, Punjab
  • S L Harikumar University School of Pharmaceutical Sciences, Rayat-Bahra University, Mohali, Punjab

Abstract

Parkinson's disease (PD) is 2nd most a neuro-degenerative disorder of the central nervous system affecting 7–10 million people of worldwide as the report of WHO 2014. It occurs due to the death of dopamine-generating cells in the substantia nigra, a region of the midbrain. It is characterized by tremor, rigidity, bradykinesia, dementia, depression and falls or emerges with the progression of the disease. Ropinirole Hydrochloride is a drug of choice which is having low molecular weight, high solubility. It is rapidly absorbed from the gastro intestinal tract and mean peak plasma concentrations have been achieved within 1.5 h after oral doses. The oral bioavailability of Ropinirole HCl is 50% due to extensive first pass metabolism by the liver. Its mean plasma half-life is 5–6hr. The present review work tries to enlighten the prior art related to Parkinson's disease treatment with Ropinirole HCl loaded nanostructured lipid carriers (NLCs) that may overcome the problem of bioavailability and bypass the blood brain barrier and targeted to the brain thereby decreasing the dosing frequency and increasing patient compliance. The promising results of NLC of Ropinirole formulation suggested in this review work provides a futuristic approach for achieving better therapeutic efficacy by being able to target CNS.

 

Keywords: Bioavailability, Parkinson's disease, nanostructured lipid carriers (NLCs), Nano-technology

 

Cite this Article

Manoj Kumar Katual, Gurfateh Singh, S.L. Harikumar. Current Prospective of NLCs in Parkinson’s Disease: An Outlook. Research & Reviews: A Journal of Drug Design & Discovery. 2018; 5(2): 18–29p.

Author Biography

  • Manoj Kumar Katual, Rayat-Bahra Institute of Pharmacy, Education city, vpo-Bohan, Tehsil& Dist: Hoshiarpur, punjab 146001
    Department of Pharmacy, Head of the institute

Downloads

Published

2018-11-01

Issue

Vol. 5 No. 2 (2018)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.